X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs WYETH LTD - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA WYETH LTD ABBOTT INDIA/
WYETH LTD
 
P/E (TTM) x 33.0 27.7 119.1% View Chart
P/BV x 8.2 5.3 154.2% View Chart
Dividend Yield % 0.8 1.3 63.9%  

Financials

 ABBOTT INDIA   WYETH LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
WYETH LTD
Mar-13
ABBOTT INDIA/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs6,0151,044 575.9%   
Low Rs3,707818 453.2%   
Sales per share (Unadj.) Rs1,236.9298.6 414.3%  
Earnings per share (Unadj.) Rs122.257.2 213.4%  
Cash flow per share (Unadj.) Rs129.058.4 220.8%  
Dividends per share (Unadj.) Rs35.0017.00 205.9%  
Dividend yield (eoy) %0.71.8 39.4%  
Book value per share (Unadj.) Rs521.2249.5 208.9%  
Shares outstanding (eoy) m21.2522.72 93.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.93.1 126.0%   
Avg P/E ratio x39.816.3 244.6%  
P/CF ratio (eoy) x37.715.9 236.4%  
Price / Book Value ratio x9.33.7 249.8%  
Dividend payout %28.629.7 96.5%   
Avg Mkt Cap Rs m103,29621,157 488.2%   
No. of employees `0003.00.5 600.8%   
Total wages/salary Rs m3,370400 842.5%   
Avg. sales/employee Rs Th8,891.813,787.4 64.5%   
Avg. wages/employee Rs Th1,140.0813.0 140.2%   
Avg. net profit/employee Rs Th878.32,643.3 33.2%   
INCOME DATA
Net Sales Rs m26,2846,783 387.5%  
Other income Rs m504353 143.1%   
Total revenues Rs m26,7897,136 375.4%   
Gross profit Rs m3,6651,617 226.6%  
Depreciation Rs m14427 542.9%   
Interest Rs m86 147.3%   
Profit before tax Rs m4,0171,938 207.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m1,421632 224.8%   
Profit after tax Rs m2,5961,301 199.6%  
Gross profit margin %13.923.8 58.5%  
Effective tax rate %35.432.6 108.4%   
Net profit margin %9.919.2 51.5%  
BALANCE SHEET DATA
Current assets Rs m14,4466,984 206.9%   
Current liabilities Rs m4,7252,056 229.8%   
Net working cap to sales %37.072.6 50.9%  
Current ratio x3.13.4 90.0%  
Inventory Days Days5199 51.8%  
Debtors Days Days2024 81.7%  
Net fixed assets Rs m1,113244 455.5%   
Share capital Rs m213227 93.5%   
"Free" reserves Rs m10,8085,441 198.6%   
Net worth Rs m11,0765,668 195.4%   
Long term debt Rs m025 0.0%   
Total assets Rs m16,2417,901 205.6%  
Interest coverage x497.0353.3 140.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.60.9 188.5%   
Return on assets %16.016.5 97.0%  
Return on equity %23.422.9 102.2%  
Return on capital %36.334.0 106.7%  
Exports to sales %0.60.2 281.8%   
Imports to sales %12.636.3 34.8%   
Exports (fob) Rs m16215 1,091.9%   
Imports (cif) Rs m3,3222,465 134.8%   
Fx inflow Rs m26815 1,763.2%   
Fx outflow Rs m3,9272,677 146.7%   
Net fx Rs m-3,659-2,662 137.5%   
CASH FLOW
From Operations Rs m2,514923 272.3%  
From Investments Rs m-800317 -252.3%  
From Financial Activity Rs m-803-481 166.9%  
Net Cashflow Rs m912759 120.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.1 146.8%  
Indian inst/Mut Fund % 7.9 11.3 69.9%  
FIIs % 0.1 7.2 1.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 30.4 56.3%  
Shareholders   18,270 21,978 83.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   AUROBINDO PHARMA  MERCK LTD  GSK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Strong; Consumer Durables Stocks Drag(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are trading above the dotted line. Except stocks in the consumer durables sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - SHASUN PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS